These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 10465073

  • 1. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
    Casado JL, Arrizabalaga J, Montes M, Martí-Belda P, Tural C, Pinilla J, Gutierrez C, Portu J, Schuurman R, Aguirrebengoa K.
    AIDS; 1999 Aug 20; 13(12):1497-502. PubMed ID: 10465073
    [Abstract] [Full Text] [Related]

  • 2. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
    Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    AIDS; 1999 Jul 09; 13(10):1203-6. PubMed ID: 10416523
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.
    Bowen EF, Sabin CA, Wilson P, Griffiths PD, Davey CC, Johnson MA, Emery VC.
    AIDS; 1997 Jun 09; 11(7):889-93. PubMed ID: 9189214
    [Abstract] [Full Text] [Related]

  • 4. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D.
    AIDS; 2000 May 26; 14(8):1041-9. PubMed ID: 10853987
    [Abstract] [Full Text] [Related]

  • 5. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL, Perez-Elías MJ, Martí-Belda P, Antela A, Suarez M, Ciancas E, Frutos B, Perez MD, Guerrero A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):130-4. PubMed ID: 9768621
    [Abstract] [Full Text] [Related]

  • 6. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 01; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Furlan V, Lantz O, Lecointe D, Delfraissy JF, Offret H.
    J Acquir Immune Defic Syndr; 1999 Nov 01; 22(3):228-34. PubMed ID: 10770342
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam.
    Colby DJ, Vo DQ, Teoh SC, Tam NT, Liem NT, Lu D, Nguyen TT, Cosimi L, Pollack T, Libman H.
    Int J STD AIDS; 2014 Jun 01; 25(7):516-22. PubMed ID: 24327723
    [Abstract] [Full Text] [Related]

  • 10. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.
    Br J Ophthalmol; 1999 Oct 01; 83(10):1186-9. PubMed ID: 10502584
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun 01; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 12. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Rudent A, Lantz O, Lecointe D, Furlan V, Delfraissy JF, Offret H.
    J Fr Ophtalmol; 1998 Oct 01; 21(8):567-76. PubMed ID: 9833222
    [Abstract] [Full Text] [Related]

  • 13. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 14. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 03; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG.
    Br J Ophthalmol; 1999 Jun 03; 83(6):652-5. PubMed ID: 10340970
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival.
    Bowen EF, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson M, Emery V.
    AIDS; 1996 Nov 03; 10(13):1515-20. PubMed ID: 8931786
    [Abstract] [Full Text] [Related]

  • 17. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M, Deayton JR, Bowen EF, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    J Med Virol; 1999 Nov 03; 59(3):323-8. PubMed ID: 10502264
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
    Jeon S, Lee WK, Lee Y, Lee DG, Lee JW.
    Ophthalmology; 2012 Sep 03; 119(9):1892-8. PubMed ID: 22657564
    [Abstract] [Full Text] [Related]

  • 19. A cross-sectional study of cytomegalovirus retinitis in HIV-1 infected adults in Nigeria.
    Adeiza MA, Habib AG.
    Niger J Clin Pract; 2019 Mar 03; 22(3):293-297. PubMed ID: 30837414
    [Abstract] [Full Text] [Related]

  • 20. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
    Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR, Phair JP.
    Arch Ophthalmol; 1996 Jul 03; 114(7):821-7. PubMed ID: 8660165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.